| 441/658 | Câncer Figueiredo MAP, Marques EF, Souza JA, Aguiar TG, Bitencourt AGV, Chojniak R. Analysis of risk factors and association between the bi-rads classification and anatomical-pathological findings in nonpalpable breast lesions. Applied Cancer Research, São Paulo: Tecmedd, v.32, n.1, p. 2-5, 2012. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br/applied/ACR2012;32(1)p.2-5.pdf CANCER DE MAMA; CLASSIFICACAO; FATOR DE RISCO; ULTRASONOGRAFIA; LESAO MAMARIA |
| 442/658 | US=49-D / Câncer Wagh PK, Peace BE, Waltz SE. Met-related receptor tyrosine kinase ron in tumor growth and metastasis. In: Woude GFV, Klein G. Advances in cancer research. v.100. Amsterdam: Elsevier, 2008. p. 1-33. ISBN 978-0-12-374358-9. RECEPTOR MET; TIROSINA-QUINASE; CRESCIMENTO TUMORAL; METASTASE; CANCER; RON. ESTRUTURA; RON. FUNCAO; RON (REGIAO ORGANIZADORA DE NUCLEOLO); MACROFAGOS; TRANSICAO EPITELIAL MESENQUIMAL; TUMORIGENESE; ANGIOGENESE; EXPRESSAO EM TUMORES HUMANOS; CANCER DE MAMA; CANCER DE PROSTATA; CANCER DE PANCREAS; CANCER DE RIM; CANCER DE BEXIGA; CANCER DE OVARIO; CANCER DE PULMAO; CANCER GASTROINTESTINAL; CANCER DE FIGADO; CANCER. TERAPIA |
| 443/658 | US=34 / Imagem Tartar M, Comstock CE, Kipper MS. Radiation therapy effects and considerations. In: ___. Breast cancer imaging: a multidisciplinary, multimodality approach. Philadelphia: Mosby Elsevier, 2008. p. 570-604. ISBN 978-0-323-04677-0. CANCER DE MAMA; RADIOTERAPIA; TERAPIA DE RADIACAO; ESTUDO DE CASO |
| 444/658 | US=06 / Câncer Rubin P, Hansen JT. Breast cancer. In: ___. TNM staging atlas. Philadelphia: J.B. Lippincott Company, 2008. p. 169-78. ISBN 978-0-7817-6021-8. |
| 445/658 | US=65 / Biol/Mol Reinheckel T, Gocheva V, Peters C, Joyce JA. Roles of cysteine proteases in tumor progression: analysis of cysteine cathepsin knockout mice in cancer models. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 281-304. ISBN 978-0-387-69056-8. PROTEASES DE CISTEINA; PROGRESSAO TUMORAL; ANALISE DE RATINHOS KNOCKOUT; CISTEINA CATEPSINA; MODELOS DE CANCER; FENOTIPOS; CARCINOGENESE; CANCER CERVICAL; CANCER PANCREATICO; CANCER DE MAMA; CANCER DE PELE; ANGIOGENESE; INVASAO TUMORAL; PROLIFERACAO DE CELULAS TUMORAIS; APOPTOSE |
| 446/658 | US=65 / Biol/Mol Christensen IJ, Pappot H, Hoyer-Hansen G. The plasminogen activation system as a source of prognostic markers in cancer. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 569-86. ISBN 978-0-387-69056-8. SISTEMA DE ATIVACAO DO PLASMINOGENIO; MARCADORES; PROGNOSTICO NO CANCER; UPA; UPAR; PAI-1; CANCER DE MAMA; CANCER COLORRETAL; CANCER DE PULMAO; CANCER GINECOLOGICO; CANCER DE PROSTATA |
| 447/658 | US=65 / Biol/Mol Pennington CJ, Pilgrim S, Span PN, Sweep FC, Edwards DR. Novel degradome markers in breast cancer. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 627-43. ISBN 978-0-387-69056-8. CANCER DE MAMA; MARCADORES DEGRADOME; ASSINATURAS DE EXPRESSAO; PERFIL DE EXPRESSAO DEGRADOME; METALOPROTEINASE POTENCIAL; MARCADORES INIBIDORES |
| 448/658 | US=67 / Biol/Mol Atieh DM, Vahdat LT. Targeted therapy for beast cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 309-42. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CANCER DE MAMA; TERAPIA-ALVO; TRASTUZUMABE; HER-2; MICROARRAY; BEVACIZUMABE; VEGF; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; LAPATINIBE; ANTICORPOS MONOCLONAIS; INIBIDOR DA TIROSINA QUINASE |
| 449/658 | US=69 / Câncer Craft BS, Moulder S. Targeted therapy in breast cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 43-59. ISBN 978-1-60327-423-4. TERAPIA-ALVO NO CANCRO DA MAMA; CANCER DE MAMA; TERAPIA BIOLOGICA; TERAPIA-ALVO; TERAPIA ADJUVANTE; DOENCA METASTATICA |
| 450/658 | US=7 / Farmacologia Wells BG, DiPiro JT, Schwinghammer TL, DiPiro Cecily V. Breast cancer. In: ___. Pharmacotherapy handbook. 7th ed. New York: McGraw-Hill, 2008. p. 679-88. ISBN 978-0-07-148501-2. CANCER DE MAMA; CANCER DE MAMA PRECOCE; CANCER DE MAMA LOCALMENTE AVANCADO; PREVENCAO DO CANCER DE MAMA |
| 451/658 | US=70 / Biol/Mol Bunz F. Tumor suppressor genes. In: ___. Principles of cancer genetics. New York: Springer, 2008. p. 77-124. ISBN 978-1-4020-6783-9. GENES SUPRESSORES DE TUMORES; FENOTIPO RECESSIVO; RETINOBLASTOMA; HIPOTESE DE KNUDSON; LOCALIZACAO CROMOSSOMICA DO GENE; INATIVACAO DO P53; SINDROME DE LI-FRAUMENI; SUSCETIBILIDADE; CANCER DE MAMA; BRCA1; BRCA2; CDKN2A; PTEN; SMAD4; NEUROFIBROMATOSE; NEOPLASIA ENDOCRINA MULTIPLA TIPO 1; SINDROMES DE CANCER EM CAMUNDONGOS |
| 452/658 | US=70 / Biol/Mol Bunz F. Genetic alternations in common cancers. In: ___. Principles of cancer genetics. New York: Springer, 2008. p. 227-57. ISBN 978-1-4020-6783-9. CANCER; ALTERACOES GENETICAS; GENES CANCERIGENOS; CANCER. INCIDENCIA; CANCER DE PULMAO; CANCER DE PROSTATA; CANCER DE MAMA; CANCER DE ENDOMETRIO; LINFOMA; CANCER DE BEXIGA; MELANOMA; CANCER DE OVARIO; CANCER DE RIM; LEUCEMIA; CANCER DE PANCREAS; CANCER DA CAVIDADE ORAL; CANCER DE FARINGE; CANCER DO COLO UTERINO; CANCER DE TIREOIDE; CANCER DE STOMACH; CANCER DO CEREBRO; CANCER DE FIGADO |
| 453/658 | US=71 / Enfermagem Holt W. Breast cancer. In: Lockwood S. Contemporary issues in women's cancers. London: Jones & Bartlett Publishers, 2008. p. 45-58. ISBN 978-0-7637-2602-7. CANCER DE MAMA; CANCER DE MAMA. DIAGNOSTICO; CANCER DE MAMA. TRATAMENTO |
| 454/658 | US=84-A / Biol/Mol Buck M, Knabbe. Transformig growth factor-B in developing and advanced cancers: hormonal regulation of transforming growth factor-B in breast cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 125-32. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. ANTIESTROGENIO; CANCER DE MAMA; ESTROGENIO; REGULACAO HORMONAL; PROGESTINA; RETINOIDE; RESISTENCIA; TGF-B |
| 455/658 | US=84-A / Biol/Mol Todorovic-Rakovic N. Transformig growth factor-B in developing and advanced cancers: TGF-B and HER2/ErbB2 and beast cancer progression. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 141-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B; HER2; CANCER DE MAMA; SMAD; RAS/MAPK; SINERGISMO; PROGRESSAO |
| 456/658 | US=84-A / Biol/Mol Yee KO, Lawler J. Transformig growth factor-B in developing and advanced cancers: regulation of angiogenesis an tumor growth by thrombospondin-1. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 401-15. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. FATOR TRANSFORMADOR DE CRESCIMENTO - B; TROMBOSPONDINA-1; ANGIOGENESE; CANCER; PLASMINOGENIO; GLIOMA; CANCER DE MAMA; MODELO DO RATO; CELULAS ENDOTELIAIS |
| 457/658 | US=84-A / Biol/Mol Hsu FJ, Teicher BA, McPherson JM. Development of inhibitors of transforming growth factor-B signaling for therapy: rationale for anti-TGF-B antibody therapy in oncology. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 757-74. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. FACTOR DE CRESCIMENTO TRANSFORMANTE-B; IMUNOSSUPRESSAO; METASTASE OSSEA; CARCINOMA DE CELULAS RENAIS; MELANOMA; CANCER DE MAMA; HORMONAL DO CANCER DA PROSTATA REFRATARIOS; CANCER DE PANCREAS; MIELOMA MULTIPLO; LINFOMA DE NAO-HOGGKIN; BIOMARCADORES |
| 458/658 | US=84-A / Biol/Mol Kohn EA, Tang B. Transformig growth factor-B in developing and advanced cancers: tumor suppresor and pro-progression roles for TGF-B in breast cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 285-307. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B; CANCER DE MAMA; TUMOR SUPRESSOR; SUPRESSOR DE TUMOR; PROMOTOR DE TUMOR; PARACRINA |
| 459/658 | US=9 / Radioterapia Motwani SB, Strom EA, McNeese MD, Buchholz TA. Practical clinical applications: breast cancer. In: Levitt SH, Purdy JA, Perez CA, Vijayakumar S. Technical basis of radiation therapy: pratical clinical applications. 4th ed rev. New York: Spriger, 2008. p. 485-510. (Medical radiology: diagnosis imaging and radiation oncology series editors; AL Baert, LW Brady, HP Heilmann, M Molls, K Sartor) ISBN 978-3-540-21338-3. |
| 460/658 | US=90 / Biol/Mol Carraway KL, Yen L, Ingalla E, Sweeney C. EGFR signaling networks: negative regulation of signaling by the EGFR family. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 169-86. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. RECEPTOR EGF; CANCER DE MAMA; ERBB2; REGULADOR NEGATIVO; UBIQUITINA LIGASE E3; CAMUNDONGOS TRANSGENICOS |